Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical implications of pharmacokinetics and pharmacodynamics of fluoroquinolones.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 15 Jul 2005

Wispelwey Brian

Abstract excerpt

This review summarizes key data illustrating the clinical importance of pharmacodynamics, particularly among the fluoroquinolone family of antibacterials. Antibacterials are often divided into 2 groups--either time-dependent or concentration-dependent agents--on the basis of their mechanism of killing. Fluoroquinolones are concentration-dependent agents, and the parameter that correlates most closely with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Infective Agents
Share to Area Under Curve

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Bacterial

Share to Fluoroquinolones

Share to Models, Animal

Share to Monte Carlo Method

Share to Pneumococcal Infections

Share to Streptococcus pneumoniae

Source

Identifiers

PMID: 15942879
DOI: 10.1086/428053

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical implications of pharmacokinetics and pharmacodynamics of fluoroquinolones.PMID 15942879Read ↗

[Pharmacodynamic and pharmacokinetic evaluation of respiratory fluoroquinolones. Guideline to selection of the most appropriate fluoroquinolone].Semantic proximity Read ↗

Modelling biphasic killing of fluoroquinolones: guiding optimal dosing regimen design.Semantic proximity Read ↗

Therapeutic options in an era of decreasing antimicrobial susceptibility.Semantic proximity Read ↗

A 30-years Review on Pharmacokinetics of Antibiotics: Is the Right Time for Pharmacogenetics?Semantic proximity Read ↗

Antibiotic resistance--what's dosing got to do with it?Semantic proximity Read ↗

The fluoroquinolones: How long will their utility last?Semantic proximity Read ↗

Biological Effects of Quinolones: A Family of Broad-Spectrum Antimicrobial AgentsSemantic proximity Read ↗

The Fluoroquinolones: An Update for the Clinical MicrobiologistSemantic proximity Read ↗

Use of an in vitro pharmacodynamic model to derive a moxifloxacin regimen that optimizes kill of Yersinia pestis and prevents emergence of resistance.Semantic proximity Read ↗

Fluoroquinolone pharmacodynamics: prospective determination of relationships between exposure and outcome.Semantic proximity Read ↗

Ubiquitous Nature of Fluoroquinolones: The Oscillation between Antibacterial and Anticancer ActivitiesSemantic proximity Read ↗

Pharmacodynamics of fosfomycin: insights into clinical use for antimicrobial resistance.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.